PFAS linkage
- PFAS exposure has been associated with thyroid hormone disruption and thyroid disease in multiple studies.
- Some research has examined thyroid cancer risk in relation to PFAS body burden, endocrine effects, and immune-system changes.
- Intake review focuses on the diagnosis type, exposure duration, water or site records, and whether other thyroid conditions were documented before cancer diagnosis.
Thyroid cancer symptoms
- A lump or swelling in the front of the neck
- Hoarseness, voice changes, or trouble speaking
- Difficulty swallowing or breathing
- Pain in the neck or throat that may radiate to the ears
- Swollen lymph nodes in the neck
Diagnosis and medical records
- Neck examination and thyroid function blood tests
- Thyroid ultrasound to evaluate nodules and lymph nodes
- Fine-needle aspiration biopsy of suspicious nodules
- Molecular testing, CT imaging, radioactive iodine scans, or staging tests when indicated
Treatment options
- Thyroid lobectomy or total thyroidectomy depending on tumor type and extent
- Radioactive iodine therapy for selected differentiated thyroid cancers
- Thyroid hormone therapy after surgery and to suppress TSH in some patients
- External beam radiation, targeted therapy, or systemic therapy for advanced disease
What patients should gather for intake
- Keep ultrasound reports, biopsy results, surgical pathology, endocrinology notes, and medication records.
- Record any history of hypothyroidism, hyperthyroidism, thyroid nodules, or abnormal thyroid labs.
- Identify drinking-water systems, private wells, military bases, industrial facilities, or firefighting foam exposure sites.
Medical and attorney advertising notice. This page is for general information only and is not medical advice. Talk with your treating clinician about diagnosis and treatment. Submitting an intake form does not create an attorney-client relationship, and cases may be referred to qualified national PFAS co-counsel.